Century Therapeutics Inc (IPSC)
US$ 1.011%
Price Chart
Key Statistics
Market Cap
$ 48.67M
P/E Ratio
0.00
Revenue (TTM)
$ 114.9M
Volume
373.89K
52W High
$ 2.05
52W Low
$ 0.34
Dividend Yield
0.00%
Beta
1.79
Technicals
50-Day MA
0.5805
200-Day MA
0.8222
52 Week High
2.05
52 Week Low
0.3418
About IPSC
Century Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of allogeneic cell therapies for the treatment of solid tumor, hematological malignancies, and autoimmune.
Employees
140
Headquarters
Philadelphia, PA
CEO
Dr. Brent Pfeiffenberger M.B.A., Pharm.D.